Nuvalent (NUVL) EBIT (2020 - 2026)

Nuvalent filings provide 7 years of EBIT readings, the most recent being -$119.4 million for Q1 2026.

  • Quarterly EBIT fell 25.94% to -$119.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$438.9 million through Mar 2026, down 36.05% year-over-year, with the annual reading at -$414.3 million for FY2025, 47.77% down from the prior year.
  • EBIT hit -$119.4 million in Q1 2026 for Nuvalent, down from -$102.2 million in the prior quarter.
  • Across five years, EBIT topped out at -$17.7 million in Q1 2022 and bottomed at -$119.4 million in Q1 2026.
  • Average EBIT over 5 years is -$61.7 million, with a median of -$52.6 million recorded in 2024.
  • The largest annual shift saw EBIT crashed 187.05% in 2022 before it dropped 18.46% in 2025.
  • Nuvalent's EBIT stood at -$29.3 million in 2022, then plummeted by 58.49% to -$46.4 million in 2023, then plummeted by 85.84% to -$86.3 million in 2024, then dropped by 18.46% to -$102.2 million in 2025, then fell by 16.8% to -$119.4 million in 2026.
  • Per Business Quant, the three most recent readings for NUVL's EBIT are -$119.4 million (Q1 2026), -$102.2 million (Q4 2025), and -$112.7 million (Q3 2025).